Anzeige
Mehr »
Login
Freitag, 17.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
Letzte Chance, bevor die Bohrer dieses "Monster"-Vorkommen bei einem 13-Millionen-Unternehmen ansteuern
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
589 Leser
Artikel bewerten:
(2)

ASTERRA Hosts Delegation to Introduce Innovative Water-Saving Technology in Italy

Finanznachrichten News

TEL AVIV, Israel, June 09, 2022hosted a delegation of 21 Italian water utilities led by officials from the Israel Trade Office to explore water saving innovation from Israel. The delegates were introduced to Israeli-based water technology companies who provided information and opportunities to bring the innovation to their utilities in Italy.

The various regions and municipalities in Italy have differing water challenges, and often their approaches and resolutions to these challenges differ. ASTERRA Chief Executive Officer, Elly Perets said, "The information shared during this summit will drive Italian water stakeholders to integrate new technologies and methodologies. They can learn from water-scarce countries such as Israel. When collaborations highlight inter-organizational innovation strategies and increase the focus on water digitalization, we see improvement in related water networks. This accelerates the drive to sustainability."

Known as a water-tech powerhouse, Israel is home to many innovative water solutions. Besides ASTERRA, some of the other Israeli water tech companies presenting included leaders in the water industry such as Mekorot, Kando, NUF, WaterGen, and Lishtot. The group also toured the Shafdan Wastewater Treatment Plant and the Palmachim Desalination Plant during their visit.

The program began with an address by Franco Masenello, an expert on leak detection and the chief executive officer of 2f Water Venture SRL. 2f Water Venture is ASTERRA's Italian channel partner and provides coordination and field support on the detection of water leaks across Italy using ASTERRA's satellite-based Recover product.

The goals and positive outcomes from this delegation are numerous. "The likely outcomes from this include increased cooperation and strengthening technology ties between Italy and Israel. We anticipate immediate positive benefits to be realized for the entire country of Italy," Perets added.

ABOUT ASTERRA

ASTERRA (formerly Utilis) provides geospatial data-driven platform solutions for water utilities, government agencies, and the greater infrastructure industry in the areas of roads, rails, dams, and mines. ASTERRA products and services use synthetic aperture radar (SAR) data from satellites and turn this data into large-scale decision support tools. The company's proprietary algorithms and highly educated scientists and engineers are the keys to their mission, to become humanity's eyes on the Earth. ASTERRA is investing in artificial intelligence (AI) to bring its products to the next level. Since 2017, ASTERRA technology has been used in over 59 countries, saving over 169,280 million gallons of potable water, reducing carbon dioxide emissions by 108,339 metric tons, and saving 423,200 MWH of energy, all in support of United Nations Sustainable Development Goals. ASTERRA is headquartered in Israel with offices in the United States, United Kingdom, and Japan. Their innovative data solutions are used in multiple verticals around the globe. For more information on ASTERRA and to learn more about their technology, visit https://asterra.io.

Media Contact
Karen Dubey
Corporate Marketing Director
inquiry@asterra.io
(858) 798-6709

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/f9383406-8a4e-4f31-aa5e-8048ef53530f


© 2022 GlobeNewswire (Europe)
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.